Researcher Position in Precision Medicine and Monogenic Diabetes

The Mohn Center for Precision Medicine in Diabetes (PRECISE-DIA) is seeking a full-time researcher (100%) for a 3-year position affiliated with the project “Beyond Type 1 Diabetes: Precision Medicine in HNF1B-MODY”, funded by Helse Vest for the period 2026–2028.

The project aims to functionally investigate the role of the transcription factor HNF-1B in diabetes. It is a collaboration between the Department of Pediatrics and Adolescent Medicine, Haukeland University Hospital, and the Faculty of Medicine, University of Bergen. The project is led by Professor and Senior Consultant Pål Rasmus Njølstad.

About the project

Diabetes and its complications are among the greatest global health challenges of the 21st century. One important subtype is Maturity‑onset Diabetes of the Young (MODY), an autosomal dominant form of diabetes and a key example of precision medicine, which is often misdiagnosed as type 1 diabetes. Pathogenic sequence variants in the transcript...